SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-022879
Filing Date
2023-08-10
Accepted
2023-08-10 08:04:34
Documents
87
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q urgn20230630_10q.htm   iXBRL 10-Q 1662366
2 EXHIBIT 10.1 ex_553803.htm EX-10.1 29972
3 EXHIBIT 10.2 ex_557241.htm EX-10.2 124042
4 EXHIBIT 31.1 ex_532896.htm EX-31.1 17127
5 EXHIBIT 31.2 ex_532897.htm EX-31.2 17106
6 EXHIBIT 32.1 ex_532898.htm EX-32.1 6488
7 EXHIBIT 32.2 ex_532899.htm EX-32.2 6473
  Complete submission text file 0001437749-23-022879.txt   6836814

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA urgn-20230630.xsd EX-101.SCH 68687
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20230630_cal.xml EX-101.CAL 49978
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20230630_def.xml EX-101.DEF 396150
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20230630_lab.xml EX-101.LAB 331762
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20230630_pre.xml EX-101.PRE 429586
81 EXTRACTED XBRL INSTANCE DOCUMENT urgn20230630_10q_htm.xml XML 865247
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 231157256
SIC: 2834 Pharmaceutical Preparations